L. L. Dever

In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.

Kazragis, R J, Dever, L L, Jorgensen, J H, Barbour, A G

Borrelia burgdorferi, the agent of Lyme disease, and B. turicatae, a neurotropic agent of relapsing fever, are susceptible to vancomycin in vitro, with an MIC of 0.5 microgram/ml. To determine the...

In vitro susceptibility testing of Borrelia burgdorferi by a dialysis culture method.

Dever, L L, Jorgensen, J H, Barbour, A G

In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.

Dever, L L, Jorgensen, J H, Barbour, A G

Borrelia burgdorferi, a spirochete and the causative agent of Lyme disease, has been reported to be susceptible to a variety of antimicrobial agents. In this investigation, the action of vancomycin,...

Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi.

Dever, L L, Jorgensen, J H, Barbour, A G

The in vitro activities of the macrolide antibiotics clarithromycin, 14-hydroxy-clarithromycin, azithromycin, and erythromycin against 19 isolates of Borrelia burgdorferi were investigated. MICs...

Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy.

Dever, L L, Smith, S M, Handwerger, S, Eng, R H

The isolation of clinical strains of enterococci requiring vancomycin for growth has only recently been reported. We describe the isolation of Enterococcus faecium requiring vancomycin for growth...

In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.

Dever, L L, Jorgensen, J H, Barbour, A G

The susceptibility of Borrelia burgdorferi, the causative agent of Lyme borreliosis, to various antimicrobial agents varies widely among published studies. These differences are probably due in part...

In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.

Kazragis, R J, Dever, L L, Jorgensen, J H, Barbour, A G

Borrelia burgdorferi, the agent of Lyme disease, and B. turicatae, a neurotropic agent of relapsing fever, are susceptible to vancomycin in vitro, with an MIC of 0.5 microgram/ml. To determine the...

In vitro susceptibility testing of Borrelia burgdorferi by a dialysis culture method.

Dever, L L, Jorgensen, J H, Barbour, A G

In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.

Dever, L L, Jorgensen, J H, Barbour, A G

Borrelia burgdorferi, a spirochete and the causative agent of Lyme disease, has been reported to be susceptible to a variety of antimicrobial agents. In this investigation, the action of vancomycin,...

Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi.

Dever, L L, Jorgensen, J H, Barbour, A G

The in vitro activities of the macrolide antibiotics clarithromycin, 14-hydroxy-clarithromycin, azithromycin, and erythromycin against 19 isolates of Borrelia burgdorferi were investigated. MICs...

Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy.

Dever, L L, Smith, S M, Handwerger, S, Eng, R H

The isolation of clinical strains of enterococci requiring vancomycin for growth has only recently been reported. We describe the isolation of Enterococcus faecium requiring vancomycin for growth...

In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.

Dever, L L, Jorgensen, J H, Barbour, A G

The susceptibility of Borrelia burgdorferi, the causative agent of Lyme borreliosis, to various antimicrobial agents varies widely among published studies. These differences are probably due in part...